Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 40 of Cingulate Inc.'s SEC filings and found 11 warrant series, 3 convertibles, 2 ATM programs, 2 equity lines, 5 shelf registrations, 2 S-1 registrations and 1 completed offering on file for CING. The latest dilution event on file is ATM sales on Aug 13, 2026. Analysis updated Oct 7, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
TENXTenax Therapeutics, Inc.
MAIAMAIA Biotechnology, Inc.
CSBRChampions Oncology, Inc.
TELOTelomir Pharmaceuticals, Inc. Common Stock
ACRVAcrivon Therapeutics, Inc. Common Stock
MNOVMediciNova, Inc.
NMADNOMAD Power Solutions, Inc.
CRDFCardiff Oncology, Inc.
CGTXCognition Therapeutics, Inc.
FBIOFortress Biotech, Inc.
RANIRani Therapeutics Holdings, Inc.
COYACoya Therapeutics, Inc.
OKYOOKYO Pharma Limited Ordinary Shares
CLLSCellectis S.A. American Depositary Shares
CRBPCorbus Pharmaceuticals Holdings, Inc.